MétaCan
Menu
Back to cohort
Record W2083554550 · doi:10.1016/j.jalz.2014.05.1585

P4‐070: A PROGRAM OF PRE‐SYMPTOMATIC EVALUATION OF EXPERIMENTAL OR NOVEL TREATMENTS FOR ALZHEIMER'S DISEASE (PREVENT‐AD): DESIGN, METHODS, AND PERSPECTIVES

2014· article· en· W2083554550 on OpenAlexaff
Jennifer Tremblay‐Mercier, Cécile Madjar, Pierre Étienne, Judes Poirier, John C.S. Breitner

Bibliographic record

VenueAlzheimer s & Dementia · 2014
Typearticle
Languageen
FieldMedicine
TopicAlzheimer's disease research and treatments
Canadian institutionsDouglas Mental Health University Institute
Fundersnot available
KeywordsDementiaMedicineMagnetic resonance imagingDiseaseCohortNeuropsychologyPsychological interventionInternal medicinePhysical therapyPsychiatryCognitionRadiology

Abstract

fetched live from OpenAlex

Brain changes in Alzheimer's disease (AD) occur decades before appearance of the first symptoms of dementia. This pre-symptomatic stage of AD presents an opportunity to test interventions that can slow the disease process and thereby delay the onset of dementia. Efficiency of this work is enhanced by enrolling persons who have a first-degree relative with AD dementia.We describe a program in such subjects designed to test whether specific interventions will likely delay dementia onset. Our new Centre for Studies on Prevention of AD (StoP-AD) is assembling such a high-risk cohort and testing effects of potential prevention strategies in pre-symptomatic individuals. The Centre's first intervention trial will examine the effects of the nonsteroidal anti-inflammatory drug naproxen over two years. Endpoints include neuropsychological measures, sensory faculties (olfaction / central auditory processing), classic AD biomarkers in cerebrospinal fluid (CSF), and structural and functional magnetic resonance imaging (MRI). To date, we have evaluated 361 people for eligibility, enrolling 192. Of these, 118 are in the naproxen trial while 74 others undergo annual observations pending possible enrollment in future trials. APOE, BDNF, HMGR Intron M and BChE K genotypes have been determined for 177 participants. Some 40% of those enrolled in the naproxen trial have agreed to a series of four lumbar punctures (LPs), and 100 LPs have been assayed to data for concentrations of total tau, P-tau, Aβ1-40 and A β 1-42. MRI and fMRI modalities include fine structural analysis, regional volumes, resting state connectivity, regional cerebral blood flow (ASL), white matter pathology and task-based fMRI. Data are managed using an adaptation of the LORIS database. Early analyses of baseline data suggest that many of the endpoints correlate with age and, more importantly, with one-another (suggesting a common underlying driver or drivers independent of age). We offer the first description of a new Centre's study design and progress to date. A second trial, now in planning, will evaluate effects of an inducer of synthesis of the cholesterol transport protein apoE, which promotes neural regeneration and repair.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.016
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.016
Threshold uncertainty score0.086

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0160.006
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0020.002
Scholarly communication0.0010.001
Open science0.0020.003
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0150.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.121
GPT teacher head0.438
Teacher spread0.316 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicAlzheimer's disease research and treatmentsFrench-language works237,207